ACEi and ARBS in hypertension and heart failure. (2014)

• Record Type: Book
• Further Information: Note: Pasquale Perrone Filardi, editor.
• Editors: Filardi, Pasquale Perrone
• Contents: Preface; Contents; Contributors; Chapter 1: Angiotensin Converting Enzyme Inhibitors and AT1 Antagonists for Treatment of Hypertension; RAS Inhibition and Blood Pressure Lowering; RAS Inhibition and Hypertension-Related Metabolic Abnormalities; Dyslipidemias; Metabolic Syndrome and Obesity; Insulin Resistance and Diabetes; RAS Inhibition and Hypertension-Related TOD; Left Ventricular Hypertrophy; Chronic Kidney Disease; Dual RAS Inhibition; Atherosclerosis; RAS Inhibition and CV Events; Stroke; Myocardial Infarction; RAS Inhibitors and Mortality; References. Chapter 2: ACE Inhibitor and Renin-Angiotensin System the Cornerstone of Therapy for Systolic Heart Failure; Definition of Heart Failure; Epidemiology, Incidence, Prevalence and Natural History of Heart Failure; Aetiology of Heart Failure; Pathophysiology of Heart Failure; The Renin-Angiotensin System; Focus on Blockade of the Renin-Angiotensin System; Trials That Support the Use of Angiotensing-Converting Enzyme Inhibitors; ACE-Inhibitors Compared with Angiotensin Receptor Blockers; Use of the ACE Inhibitors in the Hearth Failure: ESC and ACCF/AHA Guidelines; References. Chapter 3: Impact of Chronic Kidney Disease and Diabetes Mellitus on Choice of Renin Angiotensin System-Inhibitors in Patients with Hypertension and Heart Failure; Introduction; Choice of RAAS Inhibitors in Patients with Chronic Kidney Disease; Studies in Diabetic or Non-diabetic Proteinuric Kidney Disease; Studies in Non-proteinuric Kidney Disease; High Doses of RAAS-Inhibitors or Dual RAAS Blockade; Choice of Antihypertensive Treatment in Patients with Diabetes Mellitus; Effects of Antihypertensive Agents on Insulin Sensitivity; Effects of Antihypertensive Agents on New-Onset DM. Data from Hypertension Outcome Trials Evaluating New-Onset DM as a Secondary Outcome; Data from Trials and Meta-analyses Investigating the Effects of Antihypertensive Agents on Metabolic Parameters and New-Onset DM; New-Onset DM and Cardiovascular Risk; Conclusion; References; Chapter 4: Target Organ Damage and RAAS Blockade; Introduction; RAAS Dysregulation and Target Organ Damage; Monotherapy with ACEIs; Monotherapy with ARBs; Dual Therapy; Comparison Between ACEIs and ARBs; Conclusions; References; Index.
• Publisher Details: Cham : Springer
• Publication Date: 2014
• Copyright Date: 2015
• Extent: 1 online resource (x, 150 pages), illustrations (some color)
• Subjects: 616.1206; Angiotensin converting enzyme -- Inhibitors; Hypertension -- Chemotherapy; Heart failure -- Chemotherapy; HEALTH & FITNESS -- Diseases -- General; MEDICAL -- Clinical Medicine; MEDICAL -- Diseases; MEDICAL -- Evidence-Based Medicine; MEDICAL -- Internal Medicine; Angiotensin converting enzyme -- Inhibitors; Heart failure -- Chemotherapy; Hypertension -- Chemotherapy; Angiotensin-Converting Enzyme Inhibitors -- therapeutic use; Medicine & Public Health; Cardiology; Pharmacotherapy; Electronic books
• Languages: English
• ISBNs: 9783319097886; 3319097881
• Related ISBNs: 9783319097879
• Notes: Note: Online resource; title from PDF title page (SpringerLink, viewed November 4, 2014).
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.